Spruce Biosciences, Inc.
SPRB
$0.0856
-$0.0442-34.05%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -171.70% | 5.55% | 21.02% | -16.83% | 19.46% |
| Total Depreciation and Amortization | -10.00% | -16.67% | -20.00% | -6.25% | -5.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.73% | -31.24% | 7.77% | 33.61% | 16.62% |
| Change in Net Operating Assets | 204.76% | 52.13% | 25.86% | -99.68% | -155.81% |
| Cash from Operations | -124.19% | 16.95% | 25.75% | -33.45% | 8.64% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -33.57% |
| Cash from Investing | -- | -- | -- | -- | -33.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.25% | 0.25% | -0.25% | 0.25% | -0.25% |
| Issuance of Common Stock | -- | -100.00% | -71.11% | 153.52% | -- |
| Repurchase of Common Stock | -- | 100.00% | -450.00% | 99.08% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.32% | -10.96% | -60.79% | 58.88% | -36.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.25% | 16.07% | 24.46% | -517.03% | -286.58% |